Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Expectes Positive EBITDA In 2027

BRIEF-Corline Biomedical Expectes Positive EBITDA In 2027

- Corline Biomedical AB CLBIO.ST:

  • ISSUES FINANCIAL FORECAST FOR 2026 AND GUIDANCE FOR 2027

  • FORECASTS REVENUE OF SEK 16 MLN IN 2026, SEK 30 MLN IN 2027; EBITDA POSITIVE IN 2027

  • KARDIUM PARTNERSHIP ESTIMATED TO GENERATE 2 BILLION SEK TOTAL REVENUE, SEK 200 MLN ANNUAL POTENTIAL

  • KARDIUM TO OPEN COSTA RICA FACILITY EXPECTED TO CREATE ABOUT 1,000 JOBS

  • BUSINESS PLAN FULLY FINANCED; NO ADDITIONAL EXTERNAL CAPITAL REQUIRED

Source text: ID:nGNE2LZrvl

Further company coverage: CLBIO.ST


(Gdansk Newsroom)

((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Corline Biomedical AB

See all news